EP3125885

COMBINATION OF EGFR INHIBITOR AND MEK INHIBITOR FOR USE IN THE TREATMENT OF NRAS MUTATED CANCER

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    2.4.2015
  • :
    30.6.2021
  • :
    15715805.6
  • :
    1.4.2035
  • :
    COMBINATION OF EGFR INHIBITOR AND MEK INHIBITOR FOR USE IN THE TREATMENT OF NRAS MUTATED CANCER

2.4.2015
30.6.2021
  • :
    Astrazeneca AB
  • :
    151 85 Södertälje, SE
  • :
    CROSS, Darren Anthony Edward
  • :
    Cambridge Cambridgeshire CB4 0WG, GB
  • :
    EBERLEIN, Catherine Anne
  • :
    Macclesfield Cheshire SK10 4TG, GB
  • :
    201461975088 P
  • :
    4.4.2014
  • :
    US
  • :
    201462013573 P
  • :
    18.6.2014
  • :
    US
  • :
    GB2015051042
  • :
    2.4.2015
  • :
    A61K 31/4184, A61K 31/506, A61P 35/00, A61K 31/5377